Predictors of clinical improvement in a randomized effectiveness trial for primary care patients with panic disorder

Journal of Nervous and Mental Disease

Volumn 197, Issue 10, 2009, Pages 715-721

  Chavira, Denise A ^a   Stein, Murray B ^a,b   Golinelli, Daniela ^c   Sherbourne, Cathy D ^c   Craske, Michelle G ^d,e   Sullivan, Greer ^f   Bystritsky, Alexander ^e   Roy Byrne, Peter P ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RAND CORPORATION   (United States)

^d Departments of Psychology

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Effectiveness trial; Panic disorder; Predictors; Primary care

Indexed keywords

ADULT; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; AVOIDANCE BEHAVIOR; CAUCASIAN; CLINICAL ASSESSMENT; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DYSTHYMIA; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; NEUROSIS; ONSET AGE; PANIC; PATIENT IDENTIFICATION; PREDICTION; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; RACE; SOCIAL PHOBIA; TREATMENT RESPONSE; ADOLESCENT; AGED; CLINICAL TRIAL; COGNITIVE THERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PERSONALITY TEST; PHOBIA; PRIMARY HEALTH CARE; PROBABILITY; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; TREATMENT OUTCOME;

ANXIOLYTIC AGENT;

ADOLESCENT; ADULT; AGED; ANTI-ANXIETY AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PANIC DISORDER; PERSONALITY ASSESSMENT; PHOBIC DISORDERS; PRIMARY HEALTH CARE; PROBABILITY; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 70350445031     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/NMD.0b013e3181b97d4d     Document Type: Article

References (84)

1. Akaike H (1974) A new Look at statistical model identification. IEEE Trans Automat Contr. 19:716-722.
2. Albus M, Scheibe G, Scherer J (1995) Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up. J Affect Disord. 34:109-115.
3. Alvidrez J (1999) Ethnic variations in mental health attitudes and service use among low-income African American, Latina, and European American young women. Community Ment Health J. 35:515-530.
4. Alvidrez J, Azocar F (1999) Distressed women's clinic patients: Preferences for mental health treatments and perceived obstacles. Gen Hosp Psychiatry. 21: 340-347.
5. Barron F, Hunter A, Mayo R, Willoughby D (2004) Acculturation and adherence: Issues for health care providers working with clients of Mexican origin. J Transcult Nurs. 15:331-337.
6. Basoglu M, Marks IM, Swinson RP, Noshirvani H, Osullivan G, Kuch K (1994) Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure. J Affect Disord. 30:123-132.
7. Berger P, Sachs G, Amering M, Holzinger A, Bankier B, Katschnig H (2004) Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder. J Affect Disord. 80:75-78.
8. Bernstein A, Zvolensky MJ, Feldner MT, Lewis SF, Leen-Feldner EW (2005) Anxiety sensitivity taxonicity: A concurrent test of cognitive vulnerability for posttraumatic stress symptomatology among young adults. Cogn Behav Ther. 34:229-241.
9. Brick JM, Kalton G (1996) Handling missing data in survey research. Stat Meth Med Res. 5:215-238.
10. Broman-Fulks JJ, Berman ME, Rabian B, Webster MJ (2004) Effects of aerobic exercise on anxiety sensitivity. Behav Res Ther. 42:125-136.
11. Broman-Fulks JJ, Green BA, Olatunji BO, Berman ME, Arnau RC, Deacon BJ, Sawchuk CN (2008) The latent structure of anxiety sensitivity-revisited. Assessment. 15:188-203.
12. Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB (2005) Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia and panic disorder: A 12-year prospective study. Am J Psychiatry. 162:1179-1187.
13. Bystritsky A, Wagner AW, Russo JE, Stein MB, Sherbourne CD, Craske MG, Roy-Byrne PP (2005) Assessment of beliefs about psychotropic medication and psychotherapy: Development of a measure for patients with anxiety disorders. Gen Hosp Psychiatry. 27:313-318.
14. Carrera M, Herrán A, Ayuso-Mateos JL, Sierra-Biddle D, Ramírez ML, Ayestarán A, Hoyuela F, Rodríguez-Cabo B, Vázquez-Barquero JL (2006) Quality of life in early phases of panic disorder: Predictive factors. J Affect Disord. 94:127-134.
15. Chambless DL, Gracely EJ (1988) Prediction of outcome following in-vivo exposure treatment of agoraphobia. In I Hand, HU Wittchen (Eds), Panic and Phobia 2 (pp 209-220). New York: Springer Verlag.
16. Clark DM, Salkovskis PM, Hackmann A, Wells A, Ludgate J, Gelder M (1999) Brief cognitive therapy for panic disorder: A randomized controlled trial. J Consult Clin Psychol. 67:583-589.
17. Costa PT, Jr, McCrae RR (1985) The NEO Personality Inventory manual. Odessa, FL: Psychological Assessment Resources.
18. Costa PT, McCrae RR (1992) Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) Professional Manual. Odessa (FL): Psychological Assessment Resources.
19. Davidson JR, Stein DJ, Shalev AY, Yehuda R (2004) Posttraumatic stress disorder: Acquisition, recognition, course and treatment. J Neuropsychiatry Clin Neurosci. 16:135-147.
20. Epping-Jordan J, Ustun B (2000) The WHODAS II: Leveling the playing field for all disorders. WHO Bull Ment Health. 6:5-6.
21. Faravelli C, Paterniti S, Scarpato A (1995) 5-year prospective, naturalistic follow-up study of panic disorder. Compr Psychiatry. 36:271-277.
22. Haby MM, Donnely M, Corry J, Vos T (2006) Cognitive behavioural therapy for depression, panic disorder and generalized anxiety disorder: A meta-regression of factors that may predict outcome. Aust N Z J Psychiatry. 40:9-19.
23. Hazlett-Stevens H, Craske MG, Roy-Byrne PP, Sherbourne CD, Stein MB, Bystritsky A (2002) Predictors of willingness to consider medication and psychosocial treatment of panic disorder in a primary care sample. Gen Hosp Psychiatry. 24:316-321.
24. Heldt E, Manfro GG, Kipper L, Blaya C, Maltz S, Isolan L, Hirakata VN, Otto MW (2003) Treating medication-resistant panic disorder: Predictors and outcome of cognitive behavior therapy in a Brazilian public hospital. Psychother Psychosom. 72:43-48.
25. Heldt E, Manfro GG (2006) One year follow-up of pharmacotherapy-resistant patients with panic disorder treatment with cognitive-behavioral therapy: Outcome and predictors of remission. Behav Res Ther. 44:657-665.
26. Heldt E, Blaya C, Isolan L, Kipper L, Teruchkin B, Otto MW, Fleck M, Manfro GG (2006) Quality of life and treatment outcome in panic disorder: Cognitive behavior group therapy effects in patients refractory to medication treatment. Psychother Psychosom. 75:183-186.
27. Hettema JM, Prescott CA, Kendler KS (2004) Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism. Am J Psychiatry. 161:1581-1587.
28. Jylha P, Isometsa E (2006) The relationship of neuroticism and extraversion to symptoms of anxiety and depression in the general population. Depress Anxiety. 23:281-289.
29. Keijsers GPJ, Hoogduin CAL, Schaap CPDR (1994) Prognostic factors in the behavioral treatment of panic disorder with and without agoraphobia. Behav Ther. 25:689-708.
30. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005a) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 62:593-602.
31. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005b) Prevalence, severity and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 62:617-627.
32. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B (2007) Anxiety disorders in primary care: Prevalence, impairment, comorbidity and detection. Ann Intern Med. 146:317-325.
33. Li W, Zinbarg RE (2007) Anxiety sensitivity and panic attacks: A 1-year longitudinal study. Behav Modif. 31:145-161.
34. Maller RG, Reiss S (1992) Anxiety sensitivity in 1984 and panic attacks in 1987. J Anxiety Disord. 6:241-247.
35. Marks IM, Mathews AM (1979) Brief standard self-rating for phobic patients. Behav Res Ther. 17:263-267.
36. Martinsen EW, Olsen T, Tonset E, Nyland K, Aarre TF (1998) Cognitive behavioral group therapy for panic disorder in the general clinical setting: A naturalistic study with 1-year follow-up. J Clin Psychiatry. 59:437-442.
37. Mavissakalian M, Michelson L. (1986). Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. J Clin Psychiatry. 47:117-122.
38. McNally RJ, Lorenz M (1987) Anxiety sensitivity in agoraphobics. J Behav Ther Exp Psychiatry. 18:3-11.
39. Means-Christensen A, Sherbourne C, Roy-Byrne P, Craske MG, Bystritsky A, Stein MB (2003) The Composite International Diagnostic Interview (CIDI-Auto): Problems and remedies for diagnosing panic disorder and social phobia. Int J Methods Psychiatr Res. 12:167-181.
40. Mennin DS, Heimberg RG (2000) The impact fo comorbid mood and personality disorders in the cognitive-behavioral treatment of panic disorder. Clin Psychol Rev. 20:339-357.
41. Miller JD, Pilkonis PA (2006) Neuroticism and Affective Instability: The same or different? Am J Psychiatry. 163:839-845.
42. Noyes R Jr, Reich J, Christiansen J, Suelzer M, Pfohl B, Coryell WA (1990) Outcome of panic disorder. Relationship to diagnostic subtypes and comorbidity. Arch Gen Psychiatry. 47:809-818.
43. Noyes R Jr, Clancy J, Woodman C, Holt CS, Suelzer M, Christiansen J, Anderson DJ (1993) Environmental factors related to the outcome of panic disorder. J Nerv Ment Dis. 181:529-538.
44. Otto MW, Reilly-Harrington N (1999) The impact of treatment on anxiety sensitivity. In: S Taylor (Ed), Anxiety Sensitivity: Theory, Research and Treatment of the Fear of Anxiety (pp 1-336) Mahwah (NJ): Erlbaum and Lawrence.
45. Peterson R, Reiss S (1992) Anxiety Sensitivity Index Manual. Worthington (OH): International Diagnostic Systems.
46. Pollack MH, Otto MW, Sachs GS, Leon A, Shear MK, Deltito JA, Keller MB, Rosenbaum JF (1994) Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J Affect Disord. 30:273-281.
47. Prasko J, Houbova P, Novak T, Zalesky R, Espa-Cervena K, Paskova B, Vyskocilova J (2005) Influence of personality disorder on the treatment of panic disorder-comparison study. Neuro Endocrinol Lett. 26:667- 674.
48. R Development Core Team (2007) R: A language and environment for statistical computing (manual). Vienna (Austria): Foundation for Statistical Computing.
49. Rayburn NR, Otto MW (2003) Cognitive-behavioral therapy for panic disorder: A review of treatment elements, strategies and outcomes. CNS Spectr. 8:356-362.
50. Reiss S (1999) Expectancy model of fear, anxiety and panic. Clin Psychol Rev. 11:141-153.
51. Reiss S, Peterson RA, Gursky DM, McNally RJ (1986) Anxiety sensitivity, anxiety frequency and the predictions of fearfulness. Behav Res Ther. 24:1-8.
52. Reiss S (1991) Expectancy model of fear, anxiety and panic. Clin Psychol Rev. Special Issue: Applied learning theory: Research issues for the 1990s. 2:141-153.
53. Rosenberg R, Bech P, Mellergard M, Ottosson JO (1991) Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response. Acta Psychiatr Scand Suppl. 365:46-52.
54. Roy-Byrne PP, Russo J, Cowley DS, Katon WJ (2003) Unemployment and emergency room visits predict poor treatment outcome in primary care panic disorder. J Clin Psychiatry. 64:383-389.
55. Roy-Byrne PP, Craske MG, Stein MB, Sullivan G, Bystritsky A, Katon W, Golinelli D, Sherbourne CD (2005) A randomized effectiveness trial of cognitive- behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry. 62:290-298.
56. Sareen J, Jacobi F, Cox BJ, Belik SL, Clara I, Stein MB (2006) Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Arch Intern Med. 166:2109-2116.
57. Scheibe G, Nutzinger D, Buller R, Walther AU (1992) Pretreatment anxiety level as differential predictor in outpatients with panic disorder. Arzneimittelforschung. 42:1090-1094.
58. Schinka JA, Busch RM, Robichaux-Keene N (2004) A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry. 9:197-202.
59. Schmidt NB, Lerew DR, Joiner TE Jr (2000) Prospective evaluation of the etiology of anxiety sensitivity: Test of a scar model. Behav Res Ther. 38:1083-1095.
60. Schmidt NB, Kotov R, Lerew DR, Joiner TE, Ialongo NS (2005) Evaluating latent discontinuity in cognitive vulnerability to panic: A taxometric investigation Cogn Ther Res. 29:673-691.
61. Schmidt NB, Zvolensky MJ, Maner JK (2006) Anxiety sensitivity: Prospective prediction of panic attacks and Axis I pathology. J Psychiatric Res. 20:691-699.
62. Schraufnagel TJ, Wagner AW, Miranda J, Roy-Byrne PP (2006) Treating minority patients with depression and anxiety: What does the evidence tell us? Gen Hosp Psychiatry. 28:27-36.
63. Sen S, Burmeister M, Ghosh D (2004) Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxietyrelated personality traits. Am J Med Genet. 127:85-89.
64. Sharp DM, Power KG (1999) Predicting treatment outcome for panic disorder and agoraphobia in primary care. Clin Psychol Psychother. 6:355-364.
65. Slaap BR, den Boer JA (2001) The prediction of nonresponse to pharmacotherapy in panic disorder: A review. Depress Anxiety. 14:112-122.
66. Sleath B, Rubin RH, Huston SA (2003) Hispanic ethnicity, physician-patient communication and antidepressant adherence. Compr Psychiatry. 44:198-204.
67. Stein M (2005) Anxiety disorders: Somatic treatment. In H Kaplan, B Saddock (Eds), Comprehensive Textbook of Psychiatry (pp. 1780-1788). Baltimore (MD): Williams and Wilkins.
68. Stein MB, Bienvenu OJ (2004) Diagnostic classification of anxiety disorders: DSM-V and beyond. In DS Charney, EJ Nestler (Eds), The Neurobiology of Mental Illness (2nd ed, pp 525-534). New York: Oxford University Press.
69. Stein MB, Roy-Byrne PP, McQuaid JR, Laffaye C, Russo J, McCahill ME, Katon W, Craske M, Bystritsky A, Sherbourne CD (1999) Development of a brief diagnostic screen of panic disorder in primary care. Psychosom Med. 61:359-364.
70. Stein MB, Roy-Byrne PP, Craske MG, Bystritsky A, Sullivan G, Pyne JM, Katon W, Sherbourne CD (2005) Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care. 43:1164-1170.
71. Taylor S, Koch WJ, McNally RJ (1992) How does anxiety sensitivity vary across the anxiety disorders? J Anxiety Disord. 6:249-259.
72. Taylor S, Rabian B, Federoff IC (1999) Anxiety sensitivity: Problems, prospects and challenges. In S Taylor (Ed), Anxiety Sensitivity: Theory, Research and Treatment of the Fear of Anxiety (pp 339-353). Mahwah (NJ): Lawrence Erlbaum.
73. Taylor S, Zvolensky MJ, Cox BJ, Deacon B, Heimberg RG, Ledley DR, Abramowitz JS, Holaway RM, Sandin B, Stewart SH, Coles M, Eng W, Daly ES, Arrindell WA, Bouvard M, Cardenas SJ (2007) Robust dimensions of anxiety sensitivity: Development and initial validation of the Anxiety Sensitivity Index-3. Psychol Assess. 19:176-188.
74. Telch MJ, Shermis MD, Lucas JA (1989) Anxiety sensitivity: Unitary personality trait or domain-specific appraisals? J Anxiety Disord. 3:25-32.
75. Taylor S, Koch WJ, Crockett DJ (1991) Anxiety sensitivity trait anxiety and the anxiety disorders. J Anxiety Disord. 5:293-311.
76. Toni C, Perugi G, Frare F, Mata B, Vitale B, Mengali F, Recchia M, Serra G, Akiskal HS (2000) A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants. Pharmacopsychiatry. 33:121-131.
77. Warshaw M, Massion AO, Shea MT, Allsworth J, Keller M (1997) Predictors of remission in patients with panic with and without agoraphobia: Prospective 5-year follow-up data. J Nerv Ment Dis. 185:517-519.
78. Wilson KA, Hayward C (2006) Unique contributions of anxiety sensitivity to avoidance: A prospective study in adolescents. Behav Res Ther. 44:601-609.
79. Woodman CL, Noyes R, Ballenger JC, Lydiard RB, Sievers G, Mihalko D (1994) Predictors of response to alprazolam and placebo in patients with panic disorder. J Affect Disord. 30:5-13.
80. World Health Organization (1997) Composite International Diagnostic Interview (CIDI) 2.1. Geneva (Switzerland): World Health Organization.
81. Wynaden D, Chapman R, Orb A, McGowan S, Zeeman Z, Yeak S (2005) Factors that influence Asian communities' access to mental health care. Int J Ment Health Nurs. 14:88-95.
82. Yonkers KA, Bruce SE, Dyck IR, Keller MB (2003) Chronicity, relapse, and illness- course of panic disorder, social phobia and generalized anxiety disorder: Findings in men and women from 8 years of follow-up. Depress Anxiety. 17:173-179.
83. Zinbarg RE, Brown TA, Barlow DH (1997) Hierarchical structure and general factor structure saturation of the Anxiety Sensitivity Index: Evidence and implications. Psychol Assess. 9:277-284.
84. Zvolensky MJ, Forsyth JP, Bernstein A, Leen-Feldner EW (2007) A concurrent test of the anxiety sensitivity taxon: Its relation to bodily vigilance and perceptions of control over anxiety-related events in a sample of young adults. J Cogn Psychother. 21:72-90.